Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02877511 · ClinicalTrials.gov registry record · NA
Supervised Outdoor-Use Test For Sunscreen Products in Adults
A NA study, sponsored by Bayer.
- Completed
- Registry status
- NA
- Development phase
- 102
- Enrollment target
NCT02877511: Completed NA study, sponsored by Bayer.
NCT02877511 is a NA study that has completed, run by Bayer. The registered enrollment target is 102 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02877511, a NA study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
Study Summary
To assess the safety of a sunscreen product under supervised outdoor-use conditions
Interventions
- DRUG BAY987517
- DRUG Sunscreen Lotion (Y65-110)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2016-08-20 |
| Est. Completion | 2016-08-21 |
| Phase | NA |
What the finished NCT02877511 record still lists
NCT02877511 is an interventional study that assigns participants to a tested intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which BAY987517 is the first listed.
NCT02877511 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02877511 about?
NCT02877511 is a clinical study titled "Supervised Outdoor-Use Test For Sunscreen Products in Adults". To assess the safety of a sunscreen product under supervised outdoor-use conditions
What is the current status of trial NCT02877511?
This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2016-08-20. Estimated completion is 2016-08-21.
What interventions are being tested in trial NCT02877511?
The interventions under investigation include: BAY987517 (DRUG), Sunscreen Lotion (Y65-110) (DRUG).
Who is sponsoring clinical trial NCT02877511?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02877511's enrollment target sits among peer trials
102 837th of 2000 higher than 1,161 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704662 · 102 participants · NA
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
- NCT04174742 · 102 participants
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
- NCT04275362 · 102 participants
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- NCT04541082 · 102 participants · Phase 1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI